Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 484

1.

Response.

Suissa S, Ernst P.

Chest. 2019 Aug;156(2):416-417. doi: 10.1016/j.chest.2019.04.097. No abstract available.

PMID:
31395262
2.

Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: A population-based cohort study.

Filion KB, Douros A, Azoulay L, Yin H, Yu OH, Suissa S.

Br J Clin Pharmacol. 2019 Jul 5. doi: 10.1111/bcp.14056. [Epub ahead of print]

PMID:
31276600
3.

Re-evaluating Safety and Effectiveness of Dabigatran Versus Warfarin in a Nationwide Data Environment: A Prevalent New-User Design Study.

Lin HD, Lai CL, Dong YH, Tu YK, Chan KA, Suissa S.

Drugs Real World Outcomes. 2019 Sep;6(3):93-104. doi: 10.1007/s40801-019-0156-2.

PMID:
31240630
4.

Triple therapy in COPD: only for the right patient.

Suissa S, Ariel A.

Eur Respir J. 2019 Apr 18;53(4). pii: 1900394. doi: 10.1183/13993003.00394-2019. Print 2019 Apr. No abstract available.

PMID:
31000667
5.

Comparative safety of abatacept in rheumatoid arthritis with COPD: A real-world population-based observational study.

Suissa S, Hudson M, Dell'Aniello S, Shen S, Simon TA, Ernst P.

Semin Arthritis Rheum. 2019 Mar 16. pii: S0049-0172(19)30023-X. doi: 10.1016/j.semarthrit.2019.03.007. [Epub ahead of print]

PMID:
30979397
6.

Comparative Effectiveness and Safety of LABA-LAMA vs LABA-ICS Treatment of COPD in Real-World Clinical Practice.

Suissa S, Dell'Aniello S, Ernst P.

Chest. 2019 Jun;155(6):1158-1165. doi: 10.1016/j.chest.2019.03.005. Epub 2019 Mar 26.

PMID:
30922950
7.

Risk of malignant cancers in inflammatory bowel disease.

Loo SY, Vutcovici M, Bitton A, Lakatos PL, Azoulay L, Suissa S, Brassard P.

J Crohns Colitis. 2019 Mar 15. pii: jjz058. doi: 10.1093/ecco-jcc/jjz058. [Epub ahead of print]

PMID:
30874294
8.

FMR1 Reactivating Treatments in Fragile X iPSC-Derived Neural Progenitors In Vitro and In Vivo.

Vershkov D, Fainstein N, Suissa S, Golan-Lev T, Ben-Hur T, Benvenisty N.

Cell Rep. 2019 Mar 5;26(10):2531-2539.e4. doi: 10.1016/j.celrep.2019.02.026.

9.

Observational Studies in COPD: Summary of Guidance for Authors.

Suissa S, Sotgiu G, Brusasco V.

COPD. 2018 Oct;15(5):415-417. doi: 10.1080/15412555.2018.1555234. No abstract available.

PMID:
30822246
10.

Beta-Blockers in COPD: A Methodological Review of the Observational Studies.

Suissa S, Ernst P.

COPD. 2018 Oct;15(5):520-525. doi: 10.1080/15412555.2018.1554637.

PMID:
30822238
11.

Abatacept initiation in rheumatoid arthritis and the risk of serious infection: A population-based cohort study.

Montastruc F, Renoux C, Hudson M, Dell'Aniello S, Simon TA, Suissa S.

Semin Arthritis Rheum. 2019 Jun;48(6):1053-1058. doi: 10.1016/j.semarthrit.2019.01.009. Epub 2019 Jan 25.

PMID:
30772001
12.

Inhaled corticosteroids preventing pneumonia mortality: paradox or selection bias?

Suissa S.

Eur Respir J. 2019 Feb 14;53(2). pii: 1802112. doi: 10.1183/13993003.02112-2018. Print 2019 Feb. No abstract available.

PMID:
30765484
13.

Association of Aripiprazole With the Risk for Psychiatric Hospitalization, Self-harm, or Suicide.

Montastruc F, Nie R, Loo S, Rej S, Dell'Aniello S, Micallef J, Suissa S, Renoux C.

JAMA Psychiatry. 2019 Apr 1;76(4):409-417. doi: 10.1001/jamapsychiatry.2018.4149.

PMID:
30698607
14.

Concomitant Use of Direct Oral Anticoagulants with Antiplatelet Agents and the Risk of Major Bleeding in Patients with Nonvalvular Atrial Fibrillation.

Douros A, Renoux C, Yin H, Filion KB, Suissa S, Azoulay L.

Am J Med. 2019 Feb;132(2):191-199.e12. doi: 10.1016/j.amjmed.2018.10.008. Epub 2018 Oct 25.

PMID:
30691551
15.

How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias.

Platt RW, Platt R, Brown JS, Henry DA, Klungel OH, Suissa S.

Pharmacoepidemiol Drug Saf. 2019 Jan 15. doi: 10.1002/pds.4722. [Epub ahead of print]

PMID:
30648307
16.

Triple therapy trials in COPD: a precision medicine opportunity.

Suissa S, Ariel A.

Eur Respir J. 2018 Dec 13;52(6). pii: 1801848. doi: 10.1183/13993003.01848-2018. Print 2018 Dec. No abstract available.

PMID:
30545959
17.

Abatacept initiation in rheumatoid arthritis and the risk of cancer: a population-based comparative cohort study.

Montastruc F, Renoux C, Dell'Aniello S, Simon TA, Azoulay L, Hudson M, Suissa S.

Rheumatology (Oxford). 2019 Apr 1;58(4):683-691. doi: 10.1093/rheumatology/key352.

PMID:
30535094
18.

A systematic review of observational studies of the association between pioglitazone use and bladder cancer.

Ripamonti E, Azoulay L, Abrahamowicz M, Platt RW, Suissa S.

Diabet Med. 2019 Jan;36(1):22-35. doi: 10.1111/dme.13854. Epub 2018 Nov 15.

PMID:
30378165
19.

Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study.

Suissa S, Dell'Aniello S, Ernst P.

Lancet Respir Med. 2018 Nov;6(11):855-862. doi: 10.1016/S2213-2600(18)30368-0. Epub 2018 Oct 18.

PMID:
30343028
20.

Cardiovascular disease and COPD: dangerous liaisons?

Rabe KF, Hurst JR, Suissa S.

Eur Respir Rev. 2018 Oct 3;27(149). pii: 180057. doi: 10.1183/16000617.0057-2018. Print 2018 Sep 30. Review. Erratum in: Eur Respir Rev. 2018 Nov 21;27(150):.

21.

Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals.

Lederer DJ, Bell SC, Branson RD, Chalmers JD, Marshall R, Maslove DM, Ost DE, Punjabi NM, Schatz M, Smyth AR, Stewart PW, Suissa S, Adjei AA, Akdis CA, Azoulay É, Bakker J, Ballas ZK, Bardin PG, Barreiro E, Bellomo R, Bernstein JA, Brusasco V, Buchman TG, Chokroverty S, Collop NA, Crapo JD, Fitzgerald DA, Hale L, Hart N, Herth FJ, Iwashyna TJ, Jenkins G, Kolb M, Marks GB, Mazzone P, Moorman JR, Murphy TM, Noah TL, Reynolds P, Riemann D, Russell RE, Sheikh A, Sotgiu G, Swenson ER, Szczesniak R, Szymusiak R, Teboul JL, Vincent JL.

Ann Am Thorac Soc. 2019 Jan;16(1):22-28. doi: 10.1513/AnnalsATS.201808-564PS. No abstract available. Erratum in: Ann Am Thorac Soc. 2019 Feb;16(2):283.

22.

Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study.

Douros A, Dell'Aniello S, Yu OHY, Filion KB, Azoulay L, Suissa S.

BMJ. 2018 Jul 18;362:k2693. doi: 10.1136/bmj.k2693.

23.

Response to Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10.

Suissa S.

Diabetes Care. 2018 Jun;41(6):e109-e110. doi: 10.2337/dci18-0015. No abstract available.

PMID:
29784709
24.

The effect of anti-acid therapy on survival in idiopathic pulmonary fibrosis: a methodological review of observational studies.

Tran T, Suissa S.

Eur Respir J. 2018 Jun 21;51(6). pii: 1800376. doi: 10.1183/13993003.00376-2018. Print 2018 Jun. Review.

PMID:
29724921
25.

Observational Studies of Inhaled Corticosteroid Effectiveness in COPD: Lessons Learned.

Suissa S, Ernst P.

Chest. 2018 Aug;154(2):257-265. doi: 10.1016/j.chest.2018.04.006. Epub 2018 Apr 19.

PMID:
29679596
26.

Making Sense of Triple Inhaled Therapy for COPD.

Suissa S, Drazen JM.

N Engl J Med. 2018 May 3;378(18):1723-1724. doi: 10.1056/NEJMe1716802. Epub 2018 Apr 18. No abstract available.

PMID:
29669218
27.

Reduced Mortality With Sodium-Glucose Cotransporter-2 Inhibitors in Observational Studies: Avoiding Immortal Time Bias.

Suissa S.

Circulation. 2018 Apr 3;137(14):1432-1434. doi: 10.1161/CIRCULATIONAHA.117.032799. No abstract available.

PMID:
29610125
28.

Trends in initiation of direct oral anticoagulant therapies for atrial fibrillation in a national population-based cross-sectional study in the French health insurance databases.

Huiart L, Ferdynus C, Renoux C, Beaugrand A, Lafarge S, Bruneau L, Suissa S, Maillard O, Ranouil X.

BMJ Open. 2018 Mar 30;8(3):e018180. doi: 10.1136/bmjopen-2017-018180.

29.

Non-Vitamin K Antagonist Oral Anticoagulants and Risk of Serious Liver Injury.

Douros A, Azoulay L, Yin H, Suissa S, Renoux C.

J Am Coll Cardiol. 2018 Mar 13;71(10):1105-1113. doi: 10.1016/j.jacc.2018.01.009.

30.

Comparative effectiveness of novel oral anticoagulants in UK patients with non-valvular atrial fibrillation and chronic kidney disease: a matched cohort study.

Loo SY, Coulombe J, Dell'Aniello S, Brophy JM, Suissa S, Renoux C.

BMJ Open. 2018 Jan 24;8(1):e019638. doi: 10.1136/bmjopen-2017-019638.

31.

Reply to P. Autier et al.

Suissa S, Azoulay L.

J Clin Oncol. 2018 Mar 10;36(8):831-832. doi: 10.1200/JCO.2017.77.0057. Epub 2018 Jan 25. No abstract available.

PMID:
29369706
32.

Mortality Reduction in EMPA-REG OUTCOME Trial: Beyond the Antidiabetes Effect.

Suissa S.

Diabetes Care. 2018 Feb;41(2):219-223. doi: 10.2337/dc17-1059.

PMID:
29358464
33.

Food and Drug Administration-mandated Trials of Long-Acting β-Agonist Safety in Asthma. Bang for the Buck?

Suissa S, Israel E, Donohue J, Evans S, Kemp J.

Am J Respir Crit Care Med. 2018 Apr 15;197(8):987-990. doi: 10.1164/rccm.201709-1940PP. No abstract available.

PMID:
29357261
34.

Effect of Cesarean Delivery on Long-term Risk of Small Bowel Obstruction.

Abenhaim HA, Tulandi T, Wilchesky M, Platt R, Spence AR, Czuzoj-Shulman N, Suissa S.

Obstet Gynecol. 2018 Feb;131(2):354-359. doi: 10.1097/AOG.0000000000002440.

PMID:
29324607
35.

Proton-pump inhibitors and increased gastric cancer risk: time-related biases.

Suissa S, Suissa A.

Gut. 2018 Dec;67(12):2228-2229. doi: 10.1136/gutjnl-2017-315729. Epub 2018 Jan 3. No abstract available.

PMID:
29298870
36.

Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias?

Suissa S.

Diabetes Care. 2018 Jan;41(1):6-10. doi: 10.2337/dc17-1223.

PMID:
29263192
37.

Comparative effect of statins on the risk of incident Alzheimer disease.

Sinyavskaya L, Gauthier S, Renoux C, Dell'Aniello S, Suissa S, Brassard P.

Neurology. 2018 Jan 16;90(3):e179-e187. doi: 10.1212/WNL.0000000000004818. Epub 2017 Dec 15.

PMID:
29247073
38.

Temporal trends in outpatient management of incident pulmonary embolism and associated mortality.

Klil-Drori AJ, Coulombe J, Suissa S, Hirsch A, Tagalakis V.

Thromb Res. 2018 Jan;161:111-116. doi: 10.1016/j.thromres.2017.10.026. Epub 2017 Nov 6.

PMID:
29132688
39.

Prevalence of Co-existing Autoimmune Disease in Rheumatoid Arthritis: A Cross-Sectional Study.

Simon TA, Kawabata H, Ray N, Baheti A, Suissa S, Esdaile JM.

Adv Ther. 2017 Nov;34(11):2481-2490. doi: 10.1007/s12325-017-0627-3. Epub 2017 Oct 24.

40.

Sulfonylureas as Initial Treatment for Type 2 Diabetes and the Risk of Severe Hypoglycemia.

Yu O, Azoulay L, Yin H, Filion KB, Suissa S.

Am J Med. 2018 Mar;131(3):317.e11-317.e22. doi: 10.1016/j.amjmed.2017.09.044. Epub 2017 Oct 12.

PMID:
29032229
41.

Patterns of long-term use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation: Quebec observational study.

Douros A, Renoux C, Coulombe J, Suissa S.

Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1546-1554. doi: 10.1002/pds.4333. Epub 2017 Oct 6.

PMID:
28984052
42.

Long-Term Use of Long-Acting Insulin Analogs and Breast Cancer Incidence in Women With Type 2 Diabetes.

Wu JW, Azoulay L, Majdan A, Boivin JF, Pollak M, Suissa S.

J Clin Oncol. 2017 Nov 10;35(32):3647-3653. doi: 10.1200/JCO.2017.73.4491. Epub 2017 Sep 27.

PMID:
28953430
43.

The FULFIL Trial.

Suissa S, Ariel A.

Am J Respir Crit Care Med. 2018 Feb 15;197(4):542. doi: 10.1164/rccm.201708-1578LE. No abstract available.

PMID:
28950066
44.

Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events.

Douros A, Yin H, Yu OHY, Filion KB, Azoulay L, Suissa S.

Diabetes Care. 2017 Nov;40(11):1506-1513. doi: 10.2337/dc17-0595. Epub 2017 Sep 1.

PMID:
28864502
45.

Precision Medicine Urgency: The Case of Inhaled Corticosteroids in COPD.

Suissa S, Ernst P.

Chest. 2017 Aug;152(2):227-231. doi: 10.1016/j.chest.2017.05.020. No abstract available.

PMID:
28797382
46.

Long-term Use of Inhaled Corticosteroids in COPD and the Risk of Fracture.

Gonzalez AV, Coulombe J, Ernst P, Suissa S.

Chest. 2018 Feb;153(2):321-328. doi: 10.1016/j.chest.2017.07.002. Epub 2017 Jul 14.

PMID:
28716642
47.

Run-in bias in randomised trials: the case of COPD medications.

Suissa S.

Eur Respir J. 2017 Jun 22;49(6). pii: 1700361. doi: 10.1183/13993003.00361-2017. Print 2017 Jun. No abstract available.

48.

Sex, breathing and statistics.

Suissa S, Gonzalez AV, Shrier I.

Eur Respir J. 2017 May 25;49(5). pii: 1700455. doi: 10.1183/13993003.00455-2017. Print 2017 May. No abstract available.

49.

Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events.

Suissa S, Dell'Aniello S, Ernst P.

Eur Respir J. 2017 May 23;49(5). pii: 1602245. doi: 10.1183/13993003.02245-2016. Print 2017 May.

50.

Sulfonylureas and the Risks of Cardiovascular Events and Death: A Methodological Meta-Regression Analysis of the Observational Studies.

Azoulay L, Suissa S.

Diabetes Care. 2017 May;40(5):706-714. doi: 10.2337/dc16-1943. Review.

PMID:
28428321

Supplemental Content

Loading ...
Support Center